Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter Turčáni, Jana Mašková & Jozef Húska. (2020) Real-World Treatment Patterns of Disease Modifying Therapy (DMT) for Patients with Relapse-Remitting Multiple Sclerosis and Patient Satisfaction with Therapy: Results of the Non-Interventional SKARLET Study in Slovakia. Patient Preference and Adherence 14, pages 1129-1135.
Read now
Read now
Claude Mékiès, Olivier Heinzlef, Béatrice Jenny, Anne-Laure Ramelli & Pierre Clavelou. (2018) Treatment satisfaction and quality of life in patients treated with fingolimod. Patient Preference and Adherence 12, pages 899-907.
Read now
Read now
Articles from other publishers (12)
Dimos D. Mitsikostas, Anastasios Orologas, Efthimios Dardiotis, Nikolaos Fakas, Triantafyllos Doskas, Klimentini Karageorgiou, Maria Maltezou, Ioannis Iliopoulos, Michail Vikelis & Nikolaos Grigoriadis. (2023) A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod. Advances in Therapy 40:5, pages 2217-2233.
Crossref
Crossref
Yvonne C. Lee, Fengxin Lu, Joshua Colls, Dee Luo, Penny Wang, Dorothy D. Dunlop, Lutfiyya N. Muhammad, Jing Song, Kaleb Michaud & Daniel H. Solomon. (2021) Outcomes of a Mobile App to Monitor Patient‐Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis & Rheumatology 73:8, pages 1421-1429.
Crossref
Crossref
Ieva Eskyte, Ana Manzano, George Pepper, Sue Pavitt, Helen Ford, Hilary Bekker, Jeremy Chataway, Klaus Schmierer, David Meads, Edward Webb & Barbara Potrata. (2019) Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis. Multiple Sclerosis and Related Disorders 27, pages 370-377.
Crossref
Crossref
Andrew V. Thach, Carolyn M. Brown, Vivian Herrera, Rahul Sasane, Jamie C. Barner, Kentya C. Ford & Kenneth A. Lawson. (2018) Associations Between Treatment Satisfaction, Medication Beliefs, and Adherence to Disease-Modifying Therapies in Patients with Multiple Sclerosis. International Journal of MS Care 20:6, pages 251-259.
Crossref
Crossref
Penny Wang, Dee Luo, Fengxin Lu, Josephine S Elias, Adam B Landman, Kaleb D Michaud & Yvonne C Lee. (2018) A Novel Mobile App and Population Management System to Manage Rheumatoid Arthritis Flares: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 7:4, pages e84.
Crossref
Crossref
Maëlle Voirin. (2018) Dispensation des traitements de fond de la sclérose en plaques à l’officine. Actualités Pharmaceutiques 57:573, pages 26-30.
Crossref
Crossref
Tessa Eagle, Fiona Stuart, Alicia S. Chua, Allison LaRussa, Kaitlynne Leclaire, Sandra L. Cook, Tanuja Chitnis, Howard L. Weiner, Bonnie I. Glanz & Brian C. Healy. (2017) Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis. Multiple Sclerosis and Related Disorders 18, pages 196-201.
Crossref
Crossref
Oscar Fernández, Eduardo Duran, Teresa Ayuso, Luis Hernández, Inmaculada Bonaventura & Mireia Forner. (2017) Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study). PLOS ONE 12:10, pages e0185766.
Crossref
Crossref
Jelena Drulovic, Mirjana Cukic, Sanja Grgic, Evica Dincic, Ranko Raicevic, Congor Nadj, Gordana Toncev, Slobodan Vojinovic, Sarlota Mesaros, Darija Kisic Tepavcevic, Irena Dujmovic, Daliborka Tadic, Svetlana Miletic-Drakulic, Jelena Dackovic, Smiljana Kostic, Jevto Erakovic, Lorand Sakalas, Dejan Savic, Vesna Suknjaja, Vanja Martinovic, Gorica Maric & Tatjana Pekmezovic. (2017) The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries. Multiple Sclerosis and Related Disorders 11, pages 56-61.
Crossref
Crossref
Ingrid E. H. Kremer, Silvia M. A. A. Evers, Peter J. Jongen, Trudy van der Weijden, Ilona van de Kolk & Mickaël Hiligsmann. (2016) Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling. PLOS ONE 11:11, pages e0164862.
Crossref
Crossref
Rocco Haase, Jennifer S. Kullmann & Tjalf Ziemssen. (2016) Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey. Therapeutic Advances in Neurological Disorders 9:4, pages 250-263.
Crossref
Crossref
Jasem AL-Hashel, Samar F. Ahmed, Raed Behbehani & Raed Alroughani. (2014) Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait. CNS Drugs 28:9, pages 817-824.
Crossref
Crossref